Arcutis Biotherapeutics (ARQT) Non Operating Interest Expenses (2022 - 2026)
Arcutis Biotherapeutics (ARQT) posted Non Operating Interest Expenses of $3.41 million for Q2 2026, up 12.4% from $3.03 million a year earlier but down 22.0% from the prior quarter.
Powered by 
Analysis
Arcutis Biotherapeutics (ARQT) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non Operating Interest Expenses at Arcutis Biotherapeutics was $13.85 million, down 24.0% year-over-year; for FY2025, it came in at $12.08 million, down 55.5% from FY2024.
- Annual Non Operating Interest Expenses shows a three-year compound annual growth rate of -8.3% (FY2022 to FY2025).
- In prior years, Arcutis Biotherapeutics' Non Operating Interest Expenses was $27.17 million in FY2024 (-8.6%), $29.71 million in FY2023 (+89.8%) and $15.65 million in FY2022.
- Quarterly Non Operating Interest Expenses has run from a low of $1.84 million in Q1 2022 to a high of $7.76 million in Q4 2023 over five years.
- On a year-over-year basis, Non Operating Interest Expenses increased in two of the last eight quarters, with an average decline of 25.1%.
- The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q1 2023, with growth of 283.1%; the weakest was Q1 2025, with a decline of 60.1%.
- According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $4.37 million (Q1 2026), $3 million (Q4 2025) and $3.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Arcutis Biotherapeutics | 3.32 Bn | 2.60 Bn | 118.92 Mn | 3.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.41 Mn |
| Mar 31, 2026 | 4.37 Mn |
| Dec 31, 2025 | 3.00 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 2.98 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Sep 30, 2024 | 6.65 Mn |
| Jun 30, 2024 | 7.48 Mn |
| Mar 31, 2024 | 7.48 Mn |
| Dec 31, 2023 | 7.76 Mn |
| Sep 30, 2023 | 7.56 Mn |
| Jun 30, 2023 | 7.35 Mn |
| Mar 31, 2023 | 7.04 Mn |
| Dec 31, 2022 | 6.92 Mn |
| Sep 30, 2022 | 4.90 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 1.84 Mn |
API Access
Arcutis Biotherapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ARQT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ARQT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ARQT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();